TGFBR2 and neoplasm: Confirming the utility of sequestering TGF-β near PD-L1+ cell population, an independent study demonstrated the efficacy of M7824, a PDL1-TβRII trap (based on avelumab), in suppressing tumor growth and metastasis in orthotopic breast and colorectal cancer models (Lan et al., 2018).